This company listing is no longer active
OSP Stock Overview
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Osprey Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.20 |
| 52 Week High | AU$1.60 |
| 52 Week Low | AU$0.20 |
| Beta | 1.4 |
| 1 Month Change | 0% |
| 3 Month Change | -2.44% |
| 1 Year Change | -87.50% |
| 3 Year Change | -97.22% |
| 5 Year Change | -99.54% |
| Change since IPO | -99.52% |
Recent News & Updates
Shareholder Returns
| OSP | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.9% |
| 1Y | -87.5% | 13.1% | 5.7% |
Return vs Industry: OSP underperformed the Australian Medical Equipment industry which returned -20.2% over the past year.
Return vs Market: OSP underperformed the Australian Market which returned -7.6% over the past year.
Price Volatility
| OSP volatility | |
|---|---|
| OSP Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: OSP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine OSP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Mike McCormick | ospreymed.com |
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
Osprey Medical, Inc. Fundamentals Summary
| OSP fundamental statistics | |
|---|---|
| Market cap | AU$5.13m |
| Earnings (TTM) | -AU$14.45m |
| Revenue (TTM) | AU$2.82m |
1.8x
P/S Ratio-0.4x
P/E RatioIs OSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSP income statement (TTM) | |
|---|---|
| Revenue | US$1.96m |
| Cost of Revenue | US$1.26m |
| Gross Profit | US$705.22k |
| Other Expenses | US$10.75m |
| Earnings | -US$10.05m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.39 |
| Gross Margin | 35.98% |
| Net Profit Margin | -512.51% |
| Debt/Equity Ratio | 0% |
How did OSP perform over the long term?
See historical performance and comparison